Peter Soukas, MD
Interventional Cardiology · Providence, RINPI 1467447763
Payments from drug & device makers
Across 808 payments — averaging $2671.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$613K
- Inspiremd Ltd$548K
- Contego Medical, Inc$203K
- Boston Scientific$177K
- Endologix LLC$109K
- Vesper Medical$91K
- plus $418K from 29 others
Across 3 payments — averaging $5128.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$14K
- Inspiremd Ltd$1K
- Atrium Medical Corporation$375
What the payments were for
- Consulting fees$648,72481%
- Speaking & faculty fees$93,51712%
- Travel & lodging$28,8704%
- Food & beverage$26,9913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 202 | $612,607 |
| Inspiremd Ltd | 13 | $548,495 |
| Contego Medical, Inc | 23 | $202,724 |
| Boston Scientific | 151 | $177,411 |
| Endologix LLC | 103 | $108,624 |
| Vesper Medical | 7 | $90,802 |
| W. L. Gore & Associates, Inc. | 62 | $86,654 |
| Bard Peripheral Vascular, Inc. | 7 | $73,182 |
| Philips North America LLC | 13 | $56,960 |
| Surmodics, Inc. | 62 | $55,158 |
| M.a. Med Alliance S.A. | 10 | $51,900 |
| Penumbra, Inc. | 34 | $44,239 |
| Biotronik Inc. | 15 | $12,778 |
| Medtronic(2 entities) | 31 | $10,547 |
| Cordis US CORP. | 13 | $6,208 |
| EKOS Corporation | 3 | $4,702 |
| Cardinal Health 200 LLC | 6 | $3,629 |
| Cordis Corporation | 2 | $3,625 |
| Terumo Medical Corporation | 3 | $1,400 |
| Reflow Medical Inc | 5 | $1,270 |
| Canon Medical Systems USA, Inc. | 1 | $1,000 |
| Silk Road Medical, Inc. | 3 | $900 |
| Stryker | 5 | $771 |
| Inari Medical, Inc. | 7 | $766 |
| Cook Medical LLC | 6 | $510 |
| Devoro Medical Inc. | 2 | $476 |
| Cagent Vascular Inc | 6 | $395 |
| Limflow Inc. | 2 | $330 |
| Teleflex LLC | 2 | $222 |
| Abiomed | 2 | $174 |
| Inquis Medical, Inc. | 2 | $146 |
| Cardiovascular Systems Inc. | 1 | $108 |
| Amgen | 2 | $97 |
| Abbott | 1 | $90 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CGuard Prime Carotid Stent System$514,769
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$90,352
- GORE VIABAHN VBX Balloon Expandable Endo$25,155
- ENDOCROSS Device$14,015
- Torus Stent Graft System$14,015
- GORE VIABAHN Endoprosthesis with Heparin$12,882
- GENERAL - THERAPIES$9,425
- EKOSONIC$8,853
- Vascular Lithotripsy$6,375
- JETSTREAM SC$6,187
- GORE VIABAHN Endoprosthesis$5,594
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$4,887
- Ranger$4,750
- Neuroguard$4,000
- SABER$3,300
- Indigo$3,000
- Product in Development$2,790
- AngioJet Ultra 5000A$2,281
- ELUVIA$2,226
- ENROUTE Transcarotid Neuroprotection System$1,500
How this compares
$2,158,949 in reported general payments places this provider in the 95th percentile of 23 interventional cardiology providers in Rhode Island.
See all interventional cardiology providers in Rhode Island →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $69,416 |
| XareltoRivaroxaban | 55 | $44,874 |
| BrilintaTicagrelor | 43 | $32,290 |
| EntrestoSacubitril/Valsartan | 13 | $21,978 |
| Repatha SureclickEvolocumab | 11 | $16,447 |
| JardianceEmpagliflozin | 14 | $10,131 |
| Prasugrel Hcl | 53 | $4,757 |
| ClopidogrelClopidogrel Bisulfate | 206 | $2,444 |
| Atorvastatin Calcium | 159 | $1,792 |
| Ezetimibe | 17 | $1,178 |
| Metoprolol Succinate | 68 | $1,072 |
| Rosuvastatin Calcium | 62 | $989 |
| Metoprolol Tartrate | 113 | $746 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 31 | $573 |
| Lisinopril | 67 | $571 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Providence
- Jinnette AbbottProvidence$439K
- Omar HyderProvidence$155K
- Paul GordonProvidence$139K
- Marwan SaadProvidence$57K
- Douglas BurttProvidence$22K
- Hafiz ImranProvidence$18K
- Mitchel SklarProvidence$7K
- Anum AsifProvidence$6K
- Ahmed ElkaryoniProvidence$3K
- Barry SharafProvidence$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.